CRLX101 (Formerly IT-101) – A Novel Nanopharmaceutical of Camptothecin in Clinical Development

Current Bioactive Compounds - United Arab Emirates
doi 10.2174/157340711795163866
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Clinical Development of Novel Drug-Radiotherapy Combinations

Clinical Cancer Research
Cancer ResearchOncology
2018English

Development of a Novel, Multilayered Presentation Format for Clinical Practice Guidelines

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2015English

Development of Novel Anode Material for Intermediate Temperature SOFC (IT-SOFC)

Journal of Materials Chemistry A
Materials ScienceChemistrythe EnvironmentSustainabilityRenewable Energy
2016English

Successful Development and Clinical Translation of a Novel Anterior Lamellar Artificial Cornea

Journal of Tissue Engineering and Regenerative Medicine
MedicineBiomedical EngineeringBiomaterials
2019English

Technology & Recruiting 101: How It Works and Where It’s Going

Strategic HR Review
2018English

Characterization of DNA Topoisomerase-1 in Spodoptera Exigua for Toxicity Evaluation of Camptothecin and Hydoxy-Camptothecin

PLoS ONE
Multidisciplinary
2013English

Synthesis of Novel 10,11-Methylenedioxy-Camptothecin Glycoside Derivatives and Investigation of Their Anti-Tumor Effects in Vivo

RSC Advances
ChemistryChemical Engineering
2019English

Cyclosporine Pharmacokinetics in Healthy Volunteers After Ocular Administration of OTX‐101, a Novel Nanomicellar Cyclosporine Formulation

Acta Ophthalmologica
MedicineOphthalmology
2018English

Retrospective Analysis of Clinical Features in 101 Death Cases With COVID-19

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy